UK-based gene editing and modulation tech startup
Pencil Biosciences has raised €6.5M across 1 funding round from 9 investors, most recently a Seed round in Sep 2023. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-09-28 | Seed | €6.5M |
| Cheshire Life Science Fund,Jonathan Milner,Martlet Capital,Northern Gritstone,o2h Ventures,Octopus Ventures+3 more |
| View deal → |
